Pages that link to "Q37463910"
Jump to navigation
Jump to search
The following pages link to Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. (Q37463910):
Displaying 27 items.
- Antihypertensive agents for preventing diabetic kidney disease (Q24202090) (← links)
- CUBN is a gene locus for albuminuria (Q30428102) (← links)
- Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy (Q34029815) (← links)
- Role of olmesartan in combination therapy in blood pressure control and vascular function (Q34139061) (← links)
- Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population (Q34785219) (← links)
- Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study (Q35421414) (← links)
- High-normal urinary albumin-to-creatinine ratio is independently associated with metabolic syndrome in Chinese patients with type 2 diabetes mellitus: A cross-sectional community-based study (Q35571858) (← links)
- Normal range albuminuria and metabolic syndrome in South Korea: the 2011-2012 Korean National Health and Nutrition Examination Survey (Q35610944) (← links)
- Body Mass Index or Microalbuminuria, Which One is More Important for the Prediction and Prevention of Diastolic Dysfunction in Non-diabetic Hypertensive Patients? (Q35844581) (← links)
- Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus (Q36522647) (← links)
- All Components of Metabolic Syndrome Are Associated with Microalbuminuria in a Chinese Population (Q37025772) (← links)
- Proteinuria and its relation to cardiovascular disease (Q37414937) (← links)
- Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan (Q38048843) (← links)
- Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes (Q38055501) (← links)
- Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease (Q38750210) (← links)
- Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus (Q39780122) (← links)
- Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria. (Q40217934) (← links)
- Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study (Q41602365) (← links)
- Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish survey. (Q51277691) (← links)
- Which Anthropometric Parameter Is Best Related With Urinary Albumin Excretion and Creatinine Clearance in Type 2 Diabetes: Body Mass Index, Waist Circumference, Waist-to-Hip Ratio, or Conicity Index? (Q51375562) (← links)
- Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes (Q57591416) (← links)
- Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis (Q61804334) (← links)
- Expert consensus on management of diabetic patients with impairment of renal function (Q82636138) (← links)
- Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label study (Q83026716) (← links)
- L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease (Q84853460) (← links)
- Detection of Lower Albuminuria Levels and Early Development of Diabetic Kidney Disease Using an Artificial Intelligence-Based Rule Extraction Approach (Q90382980) (← links)
- Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study (Q99634166) (← links)